1. Gaikwad SS, Mhalaskar RS, Mahale YD, Jain
NP. Review on: solubility enhancement of poorlywater-soluble drug. Indo Am J
Pharm Res. 2014;4(11):5530-41.
2.
Patel R, Patel N, Patel NM, Patel M. A
novel approach for dissolution enhancement of Ibuprofen by preparing floating
granules. Int. J. Res. Pharm. Sci. 2010;1(1):57-64.
3.
Nash RA.
Suspensions,‖ in Encyclopedia of Pharmaceutical Technology, J. Swarbrick and JC
Boylan, Eds., vol. 3.
4.
Chowdary KP, Madhavi BL. Novel drug
delivery technologies for insoluble drugs. Indiandrugs-bombay. 2005;42(9):557.
5.
Humberstone AJ, Charman WN. Lipid-based
vehicles for the oral delivery of poorly water- soluble drugs. Advanced drug
delivery reviews. 1997;25(1):103-28.
6.
Spireas S,
inventor; HYGROSOL PHARMACEUTICAL CORP, assignee. Liquisolid systems and
methods of preparing same. United States patent US 6,423,339. 2002 Jul 23.
7.
Steed JW. The role of co-crystals in
pharmaceutical design. Trends in pharmacological science. 2013 Mar
1;34(3):185-93.
8.
Jones JT,
Hasell T, Wu X, Bacsa J, Jelfs KE, Schmidtmann M, Chong SY, Adams DJ, Trewin A,
Schiffman F, Cora F. Modular and predictable assembly of porous organic
molecular crystals. Nature. 2011 Jun 16;474(7351):367-71.
9.
Tayi AS,
Shveyd AK, Sue AC, Szarko JM, Rolczynski BS, Cao D, Kennedy TJ, Sarjeant AA,
Stern CL, Paxton WF, Wu W. Room-temperature ferroelectricity in supramolecular
networks of charge-transfer complexes. Nature. 2012 Aug 23;488(7412):485-9.
10.
Huang KS,
Britton D, Byrn SR. A novel class of phenol–pyridine co-crystals for second
harmonic generation. Journal of Materials Chemistry. 1997;7(5):713-20.
11.
Etter MC,
Reutzel SM. Hydrogen bond directed cocrystallization and molecular recognition
properties of acyclic imides. Journal of the American Chemical Society. 1991
Mar;113(7):2586-98.
12.
Etter MC,
Urbanczyk-Lipkowska Z, Zia-Ebrahimi M, Panunto TW. Hydrogen bond-directed
cocrystallization and molecular recognition properties of diarylureas. Journal
of the American Chemical Society. 1990 Nov;112(23):8415-26.
13.
Brittain
HG. Cocrystal systems of pharmaceutical interest: 2010. Crystal growth &
design. 2012 Feb 1;12(2):1046-54.
14.
Shan N,
Zaworotko MJ. The role of cocrystals in pharmaceutical science. Drug discovery
today. 2008 May 1;13(9-10):440-6.
15.
Jones W,
Motherwell WS, Trask AV. Pharmaceutical cocrystals: An emerging approach to
physical property enhancement. MRS bulletin. 2006 Nov;31(11):875-9.
16.
Blagden N,
Berry DJ, Parkin A, Javed H, Ibrahim A, Gavan PT, De Matos LL, Seaton CC.
Current directions in co-crystal growth. New Journal of Chemistry.
2008;32(10):1659-72.
17.
Good DJ,
RodrÃguez-Hornedo N. Solubility advantage of pharmaceutical cocrystals. Crystal
Growth and Design. 2009 May 6;9(5):2252-64.
18.
Wouters J,
Quéré L, editors. Pharmaceutical salts and co-crystals. Royal Society of
Chemistry; 2011 Nov 4.
19.
Barbour LJ,
Das D, Jacobs T, Lloyd GO, Smith VJ. Concepts and nomenclature in chemical
crystallography. Supramolecular Chemistry: From Molecules to Nanomaterials.
2012 Mar 15.
20.
Friscic T,
Jones W. Recent advances in understanding the mechanism of cocrystal formation
via grinding. Crystal Growth and Design. 2009 Mar 4;9(3):1621-37.
21.
Dunitz JD.
Crystal and co-crystal: a second opinion. CrystEngComm. 2003;5(91):506.
22.
Bis JA,
Vishweshwar P, Weyna D, Zaworotko MJ. Hierarchy of Supramolecular Synthons:
Persistent Hydroxyl Pyridine Hydrogen Bonds in Cocrystals That Contain a Cyano
Acceptor. Molecular Pharmaceutics. 2007 Jun 4;4(3):401-16.
23.
Almarsson Ö, Zaworotko MJ. Crystal
engineering of the composition of pharmaceutical phases. Do pharmaceutical
co-crystals represent a new path to improved medicines?. Chemical
communications. 2004(17):1889-96.
24.
Trask AV.
An overview of pharmaceutical cocrystals as intellectual property. Molecular
pharmaceutics. 2007 Jun 4;4(3):301-9.
25.
Aakeröy
CB, Forbes S, Desper J. Using cocrystals to systematically modulate aqueous
solubility and melting behavior of an anticancer drug. Journal of the American
Chemical Society. 2009 Dec 2;131(47):17048-9.
26.
Griesser
UJ. The importance of solvates. Polymorphism: In the pharmaceutical industry.
2006 Feb 6:211-33.
27.
Almarsson O, Zaworotko MJ. Crystal
engineering of the composition of pharmaceutical phases: Do pharmaceutical
co-crystals represent a new path to improved medicines. Chem Commun.
2004;35(17):1889-96.
28.
Khan M, Enkelmann V, Brunklaus G. Crystal
engineering of pharmaceutical co-crystals: application of methylparaben as
molecular hook. J Am Chem Soc. 2010;132(14):5254-63.
29.
Karki S, Friscic T, Jones W. Control and
interconversion of cocrystal stoichometry in grinding: stepwise mechanism for
the formation of a hydrogen-bonded cocrystal. Crysteng Comm. 2009;11(3):470-81.
30.
He GW, Jacob C, Guo LF, Chow PS, Tan RBH.
Screening for cocrystallization tendency: The role of intermolecular
interaction. J Phys Chem B. 2008;112(32):9890-5.
31.
Bis JA, Vishweshwar P, Weyna D, Zaworotko
MJ. Hierarchy of supramolecular synthons: Persistent hydroxyl pyridine hydrogen
bonds in cocrystals that contain a cyano acceptor. Mol Pharmaceutics.
2007;4(3):401-16.
32.
Vishweshwar P, McMahon JA, Bis JA,
Zaworotko MA. Pharmaceutical cocrystals. J Pharm Sci. 2006;95:499-516
33.
Jones W, Motherwell WDS, Trask AV.
Pharmaceutical co-crystals: An Emerging approach to physical property
enhancement. MRS Bull. 2006;31(11):875-9.
34.
Guidance D.
Regulatory Classification of Pharmaceutical Co-Crystals Guidance for Industry.
US Dept. of Health and Human Services FDA Center for Drug Evaluation and
Research (CDER). Rev. 2016 Aug;1.
35.
Cerreia VP, Chierotti MR, Gobetto R.
Pharmaceutical aspects of salt and cocrystal forms of APIs and characterization
challenges. Adv Drug Deliv Rev. 2017;117:86-110.
36.
Serajuddin
AT. Salt formation to improve drug solubility. Advanced drug delivery reviews.
2007 Jul 30;59(7):603-16.
37.
Good DJ, RodrÃguez-Hornedo N. Solubility
Advantage of Pharmaceutical Cocrystals. Cryst Growth Des. 2009;9(5):2252-64.
38.
Liu R.
Water-insoluble drug formulation. CRC press; 2000 Sep 30.
39.
Yalkowsky SH. Solubility and
Solubilization in Aqueous Media. American Chemical Society. New York: Oxford
University Press: 1999. J Am Chem Soc. 2000;122(40):9882.
40.
Bak A, Gore A, Yanez E, Stanton M,
Tufekcic S, Syed R, et al. The co-crystal approach to improve the exposure of a
water-insoluble compound: AMG 517 sorbic acid co-crystal characterization and
pharmacokinetics. J Pharm Sci. 2008;97(9):3942-56
41.
Trask AV, Motherwell WDS, Jones W.
Physical stability enhancement of theophylline via cocrystallization. Int J
Pharm. 2006;320(1-2):114-23
42.
Kuminek G, Cao F, Bahia de Oliveira da
Rocha A, Gonc¸alves Cardoso S, Rodrıguez-Hornedo N. Cocrystals to facilitate
delivery of poorly soluble compounds beyond-rule-of-5. Adv Drug Deliv Rev
2016;101:143-66.
43.
Weyna DR, Shattock T, Vishweshwar P,
Zaworotko MJ. Synthesis and structural characterization of cocrystals and pharmaceutical
cocrystals: mechanochemistry vs slow evaporation from solution. Cryst Growth
Des 2009;9:1106-23.
44.
Mullin JW.
Crystallization. Elsevier; 2001 May 9.
45.
ZQ, Chow PS, Tan RBH. Operating regions in
cooling cocrystallization of caffeine and glutaric acid in acetonitrile. Cryst
Growth Des 2010;10:2382-7.
46.
Rodrıguez-Hornedo N, Nehm SJ, Seefeldt KF,
Pagan-Torres Y, Falkiewicz CJ. Reaction crystallization of pharmaceutical
molecular complexes. Mol Pharm 2006;3:362-7.
47.
3. Huang Y, Zhou L, Yang W, Li Y, Yin Q. Preparation
of theophylline-benzoic acid cocrystal and on-line monitoring of
cocrystallization process in solution by Raman spectroscopy. Crystals
2019;9:329-44.
48.
Dai XL, Yao J, Wu C, Deng JH, Mo YH, Lu
TB, et al. Solubility and permeability improvement of allopurinol by
cocrystallization. Cryst Growth Des 2020;20:5160-8.
49.
Nagapudi K, Umanzor EY, Masui C.
High-throughput screening and scale-up of cocrystals using resonant acoustic
mixing. Int J Pharm 2017;521:337-45.
50.
Michalchuk AAL, Hope KS, Kennedy SR, Blanco
MV, Boldyreva EV, Pulham CR. Ball-free mechanochemistry: in situ real-time
monitoring of pharmaceutical co-crystal formation by resonant acoustic mixing.
Chem Comm 2018;54:4033-6.
51.
am Ende DJ, Anderson SR, Salan JS.
Development and scale-up of cocrystals using resonant acoustic mixing. Org
Process Res Dev 2014;18:331-41
52.
Guo M, Sun X, Chen J, Cai T.
Pharmaceutical cocrystals: A review of preparations, physicochemical properties
and applications. Acta Pharmaceutica Sinica B. 2021 Aug 1;11(8):2537-64.
53.
Kaupp G. Solid-state molecular syntheses:
complete reactions without auxiliaries based on the new solid-state mechanism.
Cryst Eng Comm 2003;5:117-33.
54.
Chadwick K, Davey R, Cross W. How does
grinding produce cocrystals? Insights from the case of benzophenone and diphenylamine.
Cryst Eng Comm 2007;9:732-4.
55.
Lien Nguyen K, Friscic T, Day GM, Gladden
LF, Jones W. Terahertz time-domain spectroscopy and the quantitative monitoring
of mechanochemical cocrystal formation. Nat Mater 2007;6:206-9.
56.
Macfhionnghaile P, Crowley CM, Mcardle P,
Erxleben A. Spontaneous solid-state co-crystallization of caffeine and urea.
Cryst Growth Des 2020;20:736-45.
57.
Fischer F, Scholz G, Benemann S, Rademann
K, Emmerling F. Evaluation of the formation pathways of cocrystal polymorphs in
liquid-assisted syntheses. Cryst Eng Comm 2014;16:8272-8.
58.
Lapidus SH, Stephens PW, Arora KK,
Shattock TR, Zaworotko MJ. A comparison of cocrystal structure solutions from
powder and single crystal techniques. Cryst Growth Des 2010;10(10):4630-7.
59.
Kumar S, Nanda A. Pharmaceutical
cocrystals: an overview. Indian J Pharm Sci 2017;79(6):858-71.
60.
Patole T, Deshpande A.
Co-crystallization-a technique for solubility enhancement. Int J Pharm Sci Res
2014;5(9):3566- 76.
61.
Xiao Y, Jin T,
Geng X, Zhu X. Azilsartan-nicotinamide cocrystal: Preparation, characterization
and in vitro/vivo evaluation. European Journal of Pharmaceutical Sciences. 2022
1;176:106241.
62.
Fayed ND, Arafa
MF, Essa EA, El Maghraby GM. Lopinavir-menthol co-crystals for enhanced
dissolution rate and intestinal absorption. Journal of Drug Delivery Science
and Technology. 2022 1;74:103587.
63.
Vogt FG, Clawson JS, Strohmeier M, Edwards
AJ, Pham TN, Watson SA. Solid-state NMR analysis of organic cocrystals and
complexes. Cryst Growth Des 2009;9(2):921-37.
64.
Kotak U, Prajapati VD, Solanki HK, Jani
GK, Jha P. Cocrystallization technique its rationale and recent progress World
J Pharm Pharm Sci 2015;4(4):1484-508.